🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 122 of 173

  1. US 7989430

    Antibacterial agents

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7985836

    Antimicrobial peptides and methods of identifying the same

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7985601

    Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7985783

    Aldehyde tags, uses thereof in site-specific protein modification

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7985401

    Peptides whose uptake by cells is controllable

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7981618

    Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7981935

    Stem cell differentiating agents and uses therefor

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7976868

    Liposomes comprising duramycin and anti-viral agents

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7977320

    Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7976743

    Gas-containing liposomes

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7976851

    Non-toxic biofilm inhibitor

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7972601

    Method of promoting delivery of an antioxidant agent to a cell expression neuroligin

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7972661

    Electrospraying method with conductivity control

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7972793

    Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7968714

    Optical determination of glucose utilizing boronic acid adducts

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7968080

    Somatostatin analogs with inhibitory activity to growth hormone release

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7968115

    Liposomal curcumin for treatment of cancer

    Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7964702

    Phalloidin derivatives and methods for their synthesis

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7964710

    EML4-ALK fusion gene

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7964573

    Regulating expression of transient receptor potential channel genes

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7964561

    Protein formulations for use at elevated temperatures

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7964712

    Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7960133

    Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7960505

    Lantibiotics and uses thereof

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7959923

    Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7960606

    Mouse model of chronic heart failure and coronary atherosclerosis regression

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7960372

    Bivalent Smac mimetics and the uses thereof

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7956028

    Protein stabilization formulations

    Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7955602

    Annexin proteins and autoantibodies as serum markers for cancer

    Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7951356

    Tissue factor compositions and kits for coagulation and tumor treatment

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7951831

    Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7951543

    Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7951845

    Composition and method of treating hearing loss

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7951362

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7947649

    Liquid buffered GDF-5 formulations

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7947726

    Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7943161

    Contrast agent coated medical device

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7943755

    Neuron regeneration

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7943332

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7943131

    Methods for protecting and regenerating bone marrow using CXCR3 agonists and antagonists

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7939495

    Method for improving skin conditions

    Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7939558

    Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof

    Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7939263

    Compositions and methods for treating and diagnosing cancer

    Expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7935357

    Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species

    Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7932382

    Conformationally constrained Smac mimetics and the uses thereof

    Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7932052

    Use of methanobactin

    Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7928138

    Marine actinomycete taxon for drug and fermentation product discovery

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7928062

    Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.